---
figid: PMC3187787__pone.0025625.g006
figtitle: B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor
  and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
organisms:
- NA
pmcid: PMC3187787
filename: pone.0025625.g006.jpg
figlink: /pmc/articles/PMC3187787/figure/pone-0025625-g006/
number: F6
caption: The standard receptor tyrosine kinase activation of the ERK pathway is shown.
  Pazopanib sensitive alterations, including HER2 overexpression and B-Raf exon 11
  mutations, are shown on the right in red. Insensitive alterations are shown on the
  left in blue. Tumor cell lines featuring each alteration are named.
papertitle: The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both
  Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models.
reftext: Brunilde Gril, et al. PLoS One. 2011;6(10):e25625.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7689628
figid_alias: PMC3187787__F6
figtype: Figure
organisms_ner:
- Danio rerio
redirect_from: /figures/PMC3187787__F6
ndex: 22cd502f-dee1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3187787__pone.0025625.g006.html
  '@type': Dataset
  description: The standard receptor tyrosine kinase activation of the ERK pathway
    is shown. Pazopanib sensitive alterations, including HER2 overexpression and B-Raf
    exon 11 mutations, are shown on the right in red. Insensitive alterations are
    shown on the left in blue. Tumor cell lines featuring each alteration are named.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - her2
  - nras
  - rab1ab
  - raf1a
  - braf
  - si:dkey-222f8.3
  - Pazopanib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
